ZymoGenetics' Acquisition

ZymoGenetics was acquired by Novo Nordisk on January 01, 1988.

Zymogenetics focuses on developing a pipeline of therapeutic proteins indulging Recothrom for hemostasis.…

Articles about ZymoGenetics' Acquisition: